
### [MONDO:0015126](http://purl.obolibrary.org/obo/MONDO_0015126)
**Label:** polyendocrinopathy

**Subclasses:** [MONDO:0017240](http://purl.obolibrary.org/obo/MONDO_0017240) (acrodysostosis with multiple hormone resistance), [MONDO:0015285](http://purl.obolibrary.org/obo/MONDO_0015285) (Carney complex), [MONDO:0019003](http://purl.obolibrary.org/obo/MONDO_0019003) (multiple endocrine neoplasia type 2), [MONDO:0017169](http://purl.obolibrary.org/obo/MONDO_0017169) (multiple endocrine neoplasia), [MONDO:0017278](http://purl.obolibrary.org/obo/MONDO_0017278) (autoimmune polyendocrinopathy), [MONDO:0015079](http://purl.obolibrary.org/obo/MONDO_0015079) (multiple polyglandular tumor), 

**Corr. equiv. classes:** [OMIM:608837](http://purl.obolibrary.org/obo/OMIM_608837), [OMIM:160980](http://purl.obolibrary.org/obo/OMIM_160980), [OMIM:162300](http://purl.obolibrary.org/obo/OMIM_162300), [Orphanet:276161](http://www.orpha.net/ORDO/Orphanet_276161), [Orphanet:280651](http://www.orpha.net/ORDO/Orphanet_280651), [OMIM:155240](http://purl.obolibrary.org/obo/OMIM_155240), [OMIM:171400](http://purl.obolibrary.org/obo/OMIM_171400), [Orphanet:282196](http://www.orpha.net/ORDO/Orphanet_282196), [OMIM:101800](http://purl.obolibrary.org/obo/OMIM_101800), [OMIM:614613](http://purl.obolibrary.org/obo/OMIM_614613), [Orphanet:100094](http://www.orpha.net/ORDO/Orphanet_100094), [OMIM:605244](http://purl.obolibrary.org/obo/OMIM_605244), [Orphanet:653](http://www.orpha.net/ORDO/Orphanet_653), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359), 

**Class expressions from DL-Learner:**

- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0100031](http://purl.obolibrary.org/obo/HP_0100031) (Neoplasm of the thyroid gland) 67.86%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) 67.86%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) 67.86%
- [HP:0000820](http://purl.obolibrary.org/obo/HP_0000820) (Abnormality of the thyroid gland) and [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) 67.86%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) 64.29%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 64.29%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) 64.29%
- [HP:0002242](http://purl.obolibrary.org/obo/HP_0002242) (Abnormality of the intestine) and [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) 64.29%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0100031](http://purl.obolibrary.org/obo/HP_0100031) (Neoplasm of the thyroid gland) 64.29%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) 64.29%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0100031](http://purl.obolibrary.org/obo/HP_0100031) (Neoplasm of the thyroid gland) 64.29%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 64.29%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) 64.29%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) 64.29%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) and [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) 64.29%


